EUSA Pharma names industry veterans to newly-created posts

UK and USA-based specialty drugmaker EUSA Pharma today announced the strengthening of its senior leadership team with the appointments of Carsten Thiel as president Europe and Darrel Cohen as head of clinical development.

Both Dr Thiel and Dr Cohen bring extensive senior level pharmaceutical company experience to these newly-created roles, and will lead EUSA’s growing commercial infrastructure in Europe and worldwide late-stage clinical development activities respectively.

Carsten Thiel brings 27 years’ commercial experience to EUSA gained in a variety of international roles in the pharmaceutical industry. Most recently he was chief executive of USA-based gene therapy specialist Abeona Therapeutics. This followed a number of years as chief commercial officer at rare disease leader Alexion Pharmaceuticals, where he previously led the company’s EMEA, Asia Pacific and Australasia organizations.